What is the emergency management for a patient with third-degree atrioventricular (AV) block on ECG?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Emergency Management of Third-Degree Atrioventricular Block

Initiate transcutaneous pacing immediately for any hemodynamically unstable patient with third-degree AV block, without waiting for atropine response, as this is the definitive emergency intervention that can prevent cardiac arrest. 1

Immediate Stabilization (First 5 Minutes)

Initial Assessment

  • Apply transcutaneous pacing pads while completing your assessment—do not delay this step. 1
  • Assess hemodynamic stability by checking for syncope, presyncope, hypotension (systolic BP <90 mmHg), altered mental status, chest pain, acute heart failure, or signs of shock. 1, 2
  • Obtain a 12-lead ECG immediately to confirm third-degree AV block and determine QRS width (narrow vs. wide), as this distinguishes AV-nodal from infranodal block and determines whether atropine will work. 1
  • Establish IV access and place patient on continuous cardiac monitoring with pulse oximetry. 1

Determine Block Location by QRS Morphology

  • Narrow QRS escape rhythm (<120 ms): Block is at the AV node level—may respond to atropine. 3, 1
  • Wide QRS escape rhythm (≥120 ms): Block is infranodal (His-Purkinje system)—will NOT respond to atropine and requires immediate pacing. 3, 1

Pharmacologic Management (Only for AV-Nodal Block)

Atropine Protocol

  • For narrow-QRS escape rhythms only: Give atropine 0.5–1 mg IV bolus, repeat every 3–5 minutes up to a total maximum dose of 3 mg. 1, 4
  • Critical pitfall: Never give doses <0.5 mg, as this may paradoxically worsen bradycardia through central vagal stimulation. 1, 4
  • Do NOT use atropine for wide-QRS escape rhythms—it is completely ineffective for infranodal blocks and wastes critical time. 3, 1

When Atropine Fails or Is Contraindicated

  • If atropine fails in AV-nodal block AND coronary ischemia is unlikely, consider β-adrenergic agonists (dopamine 5–10 µg/kg/min, dobutamine, epinephrine, or isoproterenol) only as a temporary bridge while arranging pacing. 1
  • In acute inferior MI with AV-nodal block, IV aminophylline may be considered as adjunctive therapy. 1
  • These medications are NOT primary therapy—they only buy time until pacing is established. 1

Pacing Strategy (Definitive Emergency Treatment)

Transcutaneous Pacing

  • Start immediately for any of the following: 1
    • Hemodynamically unstable patient (regardless of QRS width)
    • Wide-QRS escape rhythm (infranodal block)
    • No response to atropine after 1.5–2 mg
    • Escape rate <40 bpm
    • Pauses ≥3 seconds
  • Do NOT postpone transcutaneous pacing to give atropine in unstable patients—this is a critical error. 1

Transvenous Pacing

  • Arrange temporary transvenous pacing for patients who remain symptomatic or unstable after transcutaneous pacing, serving as a bridge to permanent pacemaker. 1
  • For anticipated prolonged temporary pacing, use an externalized permanent active-fixation lead rather than standard passive-fixation temporary leads. 1

Rule Out Reversible Causes

Before committing to permanent pacing, systematically exclude: 1, 5

  • Acute myocardial infarction (check troponin, ECG for STEMI)
  • Drug toxicity: β-blockers, calcium-channel blockers, digoxin, antiarrhythmics
  • Electrolyte abnormalities: hyperkalemia, hypomagnesemia
  • Lyme carditis (check history, serology if endemic area)
  • Myocarditis or infiltrative disease (sarcoidosis, amyloidosis)
  • Thyroid disorders (TSH, free T4)

Important: Even after correcting reversible causes, 88% of patients with third-degree AV block still require permanent pacemaker implantation. 2

Disposition and Definitive Management

Indications for Permanent Pacemaker (Class I)

  • All symptomatic patients with third-degree AV block require permanent pacemaker implantation. 3, 1
  • Asymptomatic patients with any of the following high-risk features: 3, 1
    • Documented asystole ≥3.0 seconds
    • Escape rate <40 bpm
    • Escape rhythm below the AV node (wide QRS)
    • Atrial fibrillation with pauses ≥5 seconds

Critical Pitfall

  • Never discharge an asymptomatic patient with third-degree AV block who has escape rate <40 bpm, ventricular escape rhythm, or pauses ≥3 seconds without pacemaker placement—this carries high risk of sudden death. 1, 2

Immediate Consultation

  • Contact interventional cardiology or electrophysiology immediately for all patients with third-degree AV block. 1
  • Admit to intensive care unit with continuous telemetry monitoring until permanent pacemaker is placed. 1

Special Considerations

Post-Myocardial Infarction

  • Temporary pacing is indicated for medically refractory, symptomatic bradycardia. 1
  • Observe for resolution before deciding on permanent pacing, as block may be transient. 1
  • If block persists beyond the observation period, permanent pacing is required. 1

Infranodal vs. AV-Nodal Block Prognosis

  • Infranodal blocks (wide QRS) can progress rapidly and unpredictably to asystole—require continuous monitoring and urgent pacing regardless of symptoms. 3, 1, 2
  • AV-nodal blocks (narrow QRS) have more stable junctional escape rhythms but still require close monitoring and cardiology evaluation. 3, 1

References

Guideline

Treatment of Third-Degree Atrioventricular Block

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Urgency of Treating AV Blocks

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Atrioventricular (AV) Block

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.